Condition: Oropharyngeal Squamous Cell Carcinoma (SCC) · Sponsor: BlueSky Immunotherapies GmbH
A clinical study of an immunotherapy in patients with head or neck cancers associated with the HPV16 virus
This description comes directly from the study's public registry record.
Medical University of Vienna · +43140400 · klin-pharmakologie@meduniwien.ac.at
Always discuss trial participation with your own doctor first.
| Medical University Vienna | Vienna, Austria | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06589609